October 2025
1. WANG W, Tian S, Ou Y, Yang J, et al
   FBXW5 Promotes Epithelial-Mesenchymal Transition in Lung Adenocarcinoma Through the KLF13/TROAP Signaling Pathway.
   Mol Carcinog. 2025;64:1638-1649.
   

   >> Share

   
   September 2025
2. XU S, Chen C, Liu H, Jiang S, et al
   Osteoglycin Inhibits the Progression of Lung Adenocarcinoma by Modulating ICAM1-Mediated Cell Adhesion via the PI3K/AKT Pathway.
   Mol Carcinog. 2025;64:1564-1579.
   

   >> Share

   
   
3. QIAN D, Zha D, Sang Y, Tao J, et al
   A-to-I RNA Edited miR-3167 Restrains Malignant Behaviors of Lung Adenocarcinoma by Influencing SSR2-Meditated Hippo Signaling.
   Mol Carcinog. 2025;64:1552-1563.
   

   >> Share

   
   July 2025
4. LU M, Wan T, Huang Q, Yao J, et al
   Determine the Antimetastasis Effect of Artesunate in Lung Cancer-Driven Brain Metastasis Model.
   Mol Carcinog. 2025 Jul 6. doi: 10.1002/mc.70010.
   

   >> Share

   
   
5. LIU Z, Lenz HJ, Yu J, Zhang L, et al
   Differential Response and Resistance to KRAS-Targeted Therapy.
   Mol Carcinog. 2025;64:1135-1148.
   

   >> Share

   
   
6. GONG Z, Yu F, Li C, Zhao B, et al
   Four-gene Prognostic Signature and Risk of Brain Metastasis of Lung Adenocarcinoma.
   Mol Carcinog. 2025;64:1209-1221.
   

   >> Share

   
   June 2025
7. CAO L, Xu H, Zhang A, Gao L, et al
   LINC02562 Promotes Progression of Lung Cancer by Regulating NTHL1 Dependent DNA Damage Repair Mechanisms.
   Mol Carcinog. 2025 Jun 11. doi: 10.1002/mc.23935.
   

   >> Share

   
   May 2025
8. LI X, Wu Y, Xie B, Xu M, et al
   SPP1 Promotes NSCLC Brain Metastasis Via Sequestration of Ubiquitin Ligase RNF114 to Facilitate P85alpha Ubiquitination.
   Mol Carcinog. 2025;64:829-841.
   

   >> Share

   
   March 2025
9. MAO S, Li Q, Yang Y, Liu Z, et al
   Potential Crosstalk Between ANXA1+ Epithelial Cells and FABP4+ TAM Cells of Ferroptosis-Related Molecular Clusters Promotes an Immunosuppressive Microenvironment in Non-Small Cell Lung Cancer.
   Mol Carcinog. 2025 Mar 4. doi: 10.1002/mc.23899.
   

   >> Share

   
   January 2025
10. GENG Y, Yin T, Li Y, He K, et al
    Computed Tomography-Based Radiomics and Genomics Analyses for Survival Prediction of Stage III Unresectable Non-Small Cell Lung Cancer Treated With Definitive Chemoradiotherapy and Immunotherapy.
    Mol Carcinog. 2025 Jan 21. doi: 10.1002/mc.23883.
    

    >> Share

    
    
11. LIANG H, Zhang C, Hu M, Hu F, et al
    ALKBH5-Mediated m(6)A Modification of XBP1 Facilitates NSCLC Progression Through the IL-6-JAK-STAT3 Pathway.
    Mol Carcinog. 2025;64:57-71.
    

    >> Share

    
    November 2024
12. ZHANG Y, Wang Y, Weng J, Chen J, et al
    Pyroptosis-related gene GSDMC indicates poor prognosis and promotes tumor progression by activating the AKT/mTOR pathway in lung squamous cell carcinoma.
    Mol Carcinog. 2024;63:2218-2236.
    

    >> Share

    
    
13. QIU R, Deng Y, Lu Y, Liu X, et al
    ITGB3-enriched extracellular vesicles mediate the formation of osteoclastic pre-metastatic niche to promote lung adenocarcinoma bone metastasis.
    Mol Carcinog. 2024;63:2190-2204.
    

    >> Share

    
    July 2024
14. YANG Q, Sun K, Gao T, Gao Y, et al
    SIRT1 silencing promotes EMT and Crizotinib resistance by regulating autophagy through AMPK/mTOR/S6K signaling pathway in EML4-ALK L1196M and EML4-ALK G1202R mutant non-small cell lung cancer cells.
    Mol Carcinog. 2024 Jul 30. doi: 10.1002/mc.23799.
    

    >> Share

    
    
15. LAI Q, Wan Y, Zhang Y, Huang Y, et al
    Hypomethylation-associated LINC00987 downregulation induced lung adenocarcinoma progression by inhibiting the phosphorylation-mediated degradation of SND1.
    Mol Carcinog. 2024;63:1260-1274.
    

    >> Share

    
    June 2024
16. DENG Z, Dou L, Luo Z, Liu R, et al
    AKAP95 regulates ubiquitination and degradation of cyclin Ds/Es, influencing the G1/S transition of lung cancer cells.
    Mol Carcinog. 2024 Jun 24. doi: 10.1002/mc.23781.
    

    >> Share

    
    
17. LIANG X, Xu J, Jiang Y, Yan Y, et al
    Concomitant genomic features stratify prognosis to patients with advanced EGFR mutant lung cancer.
    Mol Carcinog. 2024 Jun 11. doi: 10.1002/mc.23750.
    

    >> Share

    
    May 2024
18. CHEN C, Tang D, Xu S, Xiang L, et al
    The promotion of non-small cell lung cancer progression by collagen and calcium binding EGF domain 1 is mediated through the regulation of ERK/JNK/P38 phosphorylation by reactive oxygen species.
    Mol Carcinog. 2024 May 10. doi: 10.1002/mc.23736.
    

    >> Share

    
    
19. DU X, Cheng C, Yang Y, Fan B, et al
    NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m(5)C-dependent manner.
    Mol Carcinog. 2024;63:962-976.
    

    >> Share

    
    
20. YANG Y, Tian Z, He L, Meng H, et al
    RhoGDIbeta inhibition via miR-200c/AUF1/SOX2/miR-137 axis contributed to lncRNA MEG3 downregulation-mediated malignant transformation of human bronchial epithelial cells.
    Mol Carcinog. 2024;63:977-990.
    

    >> Share

    
    February 2024
21. FURUSAWA T, Cavero R, Liu Y, Li H, et al
    Metabolism-focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer.
    Mol Carcinog. 2024 Feb 27. doi: 10.1002/mc.23705.
    

    >> Share

    
    
22. LI Q, Li J, Wang J, Wang J, et al
    PLEK2 mediates metastasis and invasion via alpha5-nAChR activation in nicotine-induced lung adenocarcinoma.
    Mol Carcinog. 2024;63:253-265.
    

    >> Share

    
    
23. HU M, Cheng H, Yang Y, Xu L, et al
    Valproic acid increased the efficacy of EGFR TKIs on EGFR/TP53 co-mutated lung cancers and downregulated mutant-p53 levels.
    Mol Carcinog. 2024;63:275-285.
    

    >> Share

    
    January 2024
24. LI J, Li Y, Sun X, Wei L, et al
    Silencing lncRNA-DARS-AS1 suppresses nonsmall cell lung cancer progression by stimulating miR-302a-3p to inhibit ACAT1 expression.
    Mol Carcinog. 2024 Jan 30. doi: 10.1002/mc.23686.
    

    >> Share

    
    
25. ZHANG X, Zhao Y, Yiminniyaze R, Zhu N, et al
    CDK10 suppresses metastasis of lung adenocarcinoma through inhibition of the ETS2/c-Raf/p-MEK/p-ERK signaling loop.
    Mol Carcinog. 2024;63:61-74.
    

    >> Share

    
    December 2023
26. HUA T, Zhang C, Fu Y, Qin N, et al
    Integrative analyses of N6-methyladenosine-associated single-nucleotide polymorphisms (m6A-SNPs) identify tumor suppressor gene AK9 in lung cancer.
    Mol Carcinog. 2023 Dec 5. doi: 10.1002/mc.23669.
    

    >> Share

    
    
27. JIANG T, Li N, Xu H, Sun L, et al
    Identification of ATAD3A as a key regulator in non-small cell lung cancer by promoting STAT3-induced cell proliferation and tumor angiogenesis.
    Mol Carcinog. 2023 Dec 5. doi: 10.1002/mc.23667.
    

    >> Share

    
    
28. ZHANG C, Sun Q, Zhao J, Jiang N, et al
    JSI-124 inhibits cell proliferation and tumor growth by inducing autophagy and apoptosis in murine malignant mesothelioma.
    Mol Carcinog. 2023;62:1888-1901.
    

    >> Share

    
    November 2023
29. CHEN J, Kang G, Lei W, Li J, et al
    DUSP22 suppresses tumor progression by directly dephosphorylating AKT in non-small cell lung cancer.
    Mol Carcinog. 2023 Nov 8. doi: 10.1002/mc.23654.
    

    >> Share

    
    October 2023
30. LONG T, Li J, Yin T, Liu K, et al
    A genetic variant in gene NDUFAF4 confers the risk of non-small cell lung cancer by perturbing hsa-miR-215 binding.
    Mol Carcinog. 2023 Oct 3. doi: 10.1002/mc.23642.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share